|
End-of-day quote
Taipei Exchange
2026-09-07
|
5-day change | 1st Jan Change | ||
| 113.00 TWD | +5.12% |
|
+21.64% | +31.40% |
| Market Cap | 18.37B 582M 501M 471M 430M 804M 55.05B 806M 5.58B 2.16B 28.19B 2.19B 2.14B 89.8B | P/E 2026 * |
32.9x | P/E 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise Value | 16.81B 533M 458M 431M 393M 736M 50.38B 738M 5.11B 1.97B 25.8B 2B 1.96B 82.18B | EV / Sales 2026 * |
13.3x | EV / Sales 2027 * | 10.2x |
| Free-Float |
57.09% | Yield 2026 * |
1.36% | Yield 2027 * | 1.95% |
| 1 day | +5.12% | ||
| 1 week | +21.64% | ||
| Current month | +21.64% | ||
| 1 month | +33.73% | ||
| 3 months | +59.60% | ||
| 6 months | +41.60% | ||
| Current year | +31.40% |
| 1 week | 87.7 |  | 118 |
| 1 month | 74 | | 118 |
| Current year | 64.1 | | 118 |
| 1 year | 64.1 | | 154 |
| 3 years | 49.9 | | 206 |
| 5 years | 32.5 | | 221 |
| 10 years | 15.45 | | 221 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chi Yue Yang
DFI | Director of Finance/CFO | - | - |
Chun Liang Chen
IRC | Investor Relations Contact | - | 2019-06-27 |
Mei Fang Chang
PRN | Corporate Officer/Principal | - | 2016-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Fang Yue Liu
CHM | Chairman | - | 2005-10-31 |
Mei Fang Chang
BRD | Director/Board Member | - | 2016-03-07 |
Kuei Ching Wang
BRD | Director/Board Member | - | 2017-09-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.12% | +21.64% | +37.47% | -27.80% | 552M | |
| -0.21% | -4.52% | +18.91% | +67.25% | 48.26B | |
| +0.34% | -5.00% | +38.85% | +117.44% | 40.5B | |
| +0.72% | -1.01% | -10.20% | +11.66% | 11.85B | |
| +3.29% | -0.38% | +14.11% | +82.76% | 11.83B | |
| -1.50% | -0.38% | +24.76% | +138.18% | 9.36B | |
| -0.86% | -3.20% | +23.76% | +38.38% | 7.5B | |
| +0.10% | -2.60% | +36.28% | -13.54% | 7.37B | |
| +0.60% | -1.13% | +19.49% | +208.86% | 7.28B | |
| -0.32% | -1.85% | -46.31% | +22.01% | 5.19B | |
| Average | +0.73% | +0.91% | +15.71% | +64.52% | 14.97B | |
| Weighted average by Cap. | +0.25% | -1.73% | +20.92% | +81.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.27B 40.19M 34.56M 32.51M 29.67M 55.5M 3.8B 55.68M 385M 149M 1.95B 151M 148M 6.2B | 1.58B 50.01M 43.01M 40.45M 36.93M 69.06M 4.73B 69.29M 480M 185M 2.42B 188M 184M 7.72B |
| Net income | 561M 17.78M 15.29M 14.38M 13.13M 24.55M 1.68B 24.63M 171M 65.91M 861M 66.77M 65.31M 2.74B | 800M 25.35M 21.81M 20.51M 18.72M 35.01M 2.4B 35.13M 243M 93.99M 1.23B 95.22M 93.14M 3.91B |
| Net Debt | -1.56B -49.35M -42.44M -39.91M -36.44M -68.14M -4.67B -68.37M -473M -183M -2.39B -185M -181M -7.61B | -2.24B -70.9M -60.97M -57.35M -52.35M -97.91M -6.71B -98.22M -680M -263M -3.43B -266M -260M -10.94B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | NT$113.00 | +5.12% | 9,390,631 |
| 26-09-04 | NT$107.50 | +9.69% | 6,839,068 |
| 26-09-03 | NT$98.00 | +2.73% | 3,585,346 |
| 26-09-02 | NT$95.40 | +9.91% | 2,922,498 |
| 26-09-01 | NT$86.80 | -6.57% | 4,752,630 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
113.00TWD
Average target price
83.00TWD
Spread / Average Target
-26.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6620 Stock
Select your edition
All financial news and data tailored to specific country editions
